METABOLOMIC APPROACHES APPLIED TO THE STUDY OF CERVICAL CANCER: A SYSTEMATIC REVIEW

ABSTRACT

Background: Cervical cancer (CC) is the fourth leading cause of cancer among women in the world. Metabolomics can provide a deeper understanding of the underlying metabolic alterations associated with its pathophysiology.

Objective: To systematically analyze metabolomic approaches and findings used in the study of cervical cancer.

Selection Criteria: Studies that included the use of metabolomics, obtained through biological samples, from patients diagnosed with CC.

Data collection and Analysis: The review was conducted according to the PRISMA guidelines, and registered in PROSPERO. The terms of Medical Subject Headings (MeSH) and Health Sciences Descriptors (DeCS) corresponding to “Metabolomics” and “Cervical Cancer” were used as descriptors. Article quality was reviewed based on the QUADOMICS criteria.

Results: A total of 17 articles were selected for systematic review. Study quality evaluation using QUADOMICS demonstrated heterogeneous results. The main changes in metabolite levels associated with cervical cancer were identified in alanine, creatine, valine, tyrosine, isoleucine, phosphatidylcholine, acetate, lactate and β-glucose. Some amino acid levels were reduced in patients with CC and changes in energy metabolism pathways were observed. Eight articles tested the diagnostic capacity of metabolomics, obtaining results for sensitivity > 90%, specificity between 73% and 99% and AUC between 0.78 and 0.99.

Conclusion: The results suggest that patients with CC present alterations in energy metabolism, amino acids and glycerolphospholipids, pointing to a potential group of specific biomarkers.

Keywords:

Metabolomics - Uterine Cervical Neoplasms - Metabolic Networks and Pathways - Biomarkers

Publikationsverlauf

Eingereicht: 03. Januar 2022

Angenommen: 08. Juli 2022

Artikel online veröffentlicht:
29. September 2022

• REFERENCES

• 1 World Health Organization, International Agency for Research on Cancer. Globocan. (World) in 2018, all cancers, females, all ages. World Heal Organ [internet]. 2018 [Access in: 09/02/2020]. Available in: https://cutt.ly/ihjmtKW
• 2 Instituto Nacional de Câncer (Brasil). Estimativa 2020. Incidência do Câncer no Brasil. Rio de Janeiro: INCA; 2020. . [Access in: 09/02/2020]. [Internet] Available in: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdf
• 3 Instituto Nacional de Câncer (Brasil). Atlas da Mortalidade. [Internet]. 2020 [Access in: 09/02/2020]. Available in: https://mortalidade.inca.gov.br/MortalidadeWeb/
• 4 Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol [Internet] 2018; [Access in: 09/19/2020]; 47: 14-26 Available in: https://doi.org/10.1016/j.bpobgyn.2017.08.006
• 5 Petry KU. HPV and cervical cancer. Scand J Clin Lab Invest Suppl. [Internet] 2014; [Access in: 09/02/2020]; 244: 59-62 Available in: https://doi.org/10.3109/00365513.2014.936683
• 6 Li B, He X, Jia W, Li H. Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review. Molecules. [Internet] 2017; [Access in: 09/02/2020]; 22 (07) 1-10 Available in: ttps://doi.org/10.3390/molecules22071173
• 7 Kumar A, Misra BB. Challenges and Opportunities in Cancer Metabolomics. Proteomics. [Internet] 2019; [Access in: 09/02/2020]; 19: 21-22 Available in: https://doi.org/10.1002/pmic.201900042
• 8 Galvão TF, Pansani TSA, Harrad D. Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiol e Serviços Saúde. [Internet] 2015; [Access in: 10/10/2020]; 24 (02) 335-342 Available in: https://doi.org/10.5123/S1679-49742015000200017
• 9 Lumbreras B, Porta M, Márquez S, Pollán M, Parker LA, Hernández-Aguado I. QUADOMICS: An adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of '-omics'-based technologies. Clin Biochem [Internet] 2008; [Access in: 10/10/2020]; 41 16-17 1316-1325 Available in: http://dx.doi.org/10.1016/j.clinbiochem.2008.06.018
• 10 Whiting P, Rutjes A. W, Reitsma J. B, Bossuyt P. M, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC medical research methodology. [Internet] 2003; [Access in: 10/9/2020]; 3: 25-25 Available in: https://doi.org/10.1186/1471-2288-3-25
• 11 Abudula A, Rouzi N, Xu L, Yang Y, Hasimu A. Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection. Bosnian journal of basic medical sciences. [Internet] 2020; [Access in: 09/28/2020]; 20 (01) 78-87 Available in: https://doi.org/10.17305/bjbms.2019.4359
• 12 Rodríguez-Esquivel M, Rosales J, Castro R, Apresa-García T, Garay Ó, Romero-Morelos P, Marrero-Rodríguez D, Taniguchi-Ponciano K, López-Romero R, Guerrero-Flores H, Morales B, Mendoza-Rodríguez M, Mosso-Lara D, Núñez-Nolasco I, Castro-Alba P, Meza-Toledo S. E, Salcedo M. Volatolome of the Female Genitourinary Area: Toward the Metabolome of Cervical Cancer. Archives of medical research. [Internet] 2018; [Access in: 09/28/2020]; 49 (01) 27-35 Available in: https://doi.org/10.1016/j.arcmed.2018.04.004
• 13 Ilhan Z. E, Łaniewski P, Thomas N, Roe D. J, Chase D. M, Herbst-Kralovetz M. M. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. [Internet] 2019; [Access in: 09/28/2020]; 44: 675-690 Available in: https://doi.org/10.1016/j.ebiom.2019.04.028
• 14 Khan I, Nam M, Kwon M, Seo S. S, Jung S, Han J. S, Hwang G. S, Kim M. K. LC/MS-Based Polar Metabolite Profiling Identified Unique Biomarker Signatures for Cervical Cancer and Cervical Intraepithelial Neoplasia Using Global and Targeted Metabolomics. Cancers. [Internet] 2019; [Access in: 09/28/2020]; 11 (04) 511-511 Available in: https://doi.org/10.3390/cancers11040511
• 15 Paraskevaidi M, Cameron S, Whelan E, Bowden S, Tzafetas M, Mitra A, Semertzidou A, Athanasiou A, Bennett P. R, MacIntyre D. A, Takats Z, Kyrgiou M. Laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a metabolomics platform in cervical cancer screening. EBioMedicine [Internet] 2020; [Access in: 09/28/2020]; 60: 103017-103017 Available in: https://doi.org/10.1016/j.ebiom.2020.103017
• 16 Yang K, Xia B, Wang W, Cheng J, Yin M, Xie H, Li J, Ma L, Yang C, Li A, Fan X, Dhillon H. S, Hou Y, Lou G, Li K. A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer. Scientific reports. [Internet] 2017; [Access in: 10/13/2020]; 7: 43353-43353 Available in: https://doi.org/10.1038/srep43353
• 17 Ye N, Liu C, Shi P. Metabolomics analysis of cervical cancer, cervical intraepithelial neoplasia and chronic cervicitis by 1H NMR spectroscopy. European journal of gynaecological oncology. [Internet] 2015; [Access in: 10/13/2020]; 36 (02) 174-180 Available in: https://pubmed.ncbi.nlm.nih.gov/26050356/
• 18 Zhou H, Li Q, Wang T, Liang H, Wang Y, Duan Y, Song M, Wang Y, Jin H. Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics. Medicine. [Internet] 2019; [Access in: 10/13/2020]; 98 (26) e16192 Available in: https://doi.org/10.1097/MD
• 19 De Silva S. S, Payne G. S, Thomas V, Carter P. G, Ind T. E, deSouza N. M. Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31) P magic angle spinning MRS of intact tissue. NMR in biomedicine. [Internet] 2009; [Access in: 10/13/2020]; 22 (02) 1316-1325 191–19841(16–17) Available in: https://doi.org/10.1002/nbm.1302
• 20 Hasim A, Ali M, Mamtimin B, Ma J. Q, Li Q. Z, Abudula A. Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1) H NMR spectroscopy. Experimental and therapeutic medicine. [Internet] 2012; [Access in: 10/10/2020]; 3 (06) 945-951 Available in: https://doi.org/10.3892/etm.2012.509
• 21 Hasim A, Aili A, Maimaiti A, Mamtimin B, Abudula A, Upur H. Plasma-free amino acid profiling of cervical cancer and cervical intraepithelial neoplasia patients and its application for early detection. Molecular biology reports. [Internet] 2013; [Access in: 10/13/2020]; 40 (10) 5853-5859 Available in: https://doi.org/10.1007/s11033-013-2691-3
• 22 Shi P, Zhang L, Ye N. Serum Metabolomic Analysis of Cervical Cancer Patients by Gas Chromatography-Mass Spectrometry. Asian J. Chem. [Internet] 2015; [Access in: 10/13/2020]; 27 (02) 547-551 Available in: https://doi.org/10.14233/ajchem.2015.17027
• 23 Sitter B, Bathen T, Hagen B, Arentz C, Skjeldestad F. E, Gribbestad I. S. Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy. Magma (New York, N.Y.). [Internet] 2004; [Access in: 10/13/2020]; 16 (04) 174-181 Available in: https://doi.org/10.1007/s10334-003-0025-5
• 24 Yin M. Z, Tan S, Li X, Hou Y, Cao G, Li K, Kou J, Lou G. (2016). Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. [Internet] [Access in: 10/13/2020]; 37 (04) 5485-5492 2016. Available in: https://doi.org/10.1007/s13277-015-4164-x
• 25 Chen X, Yi C, Yang M. J, Sun X, Liu X, Ma H, Li Y, Li H, Wang C, He Y, Chen G, Chen S, Yu L, Yu D. (2021). Metabolomics study reveals the potential evidence of metabolic reprogramming towards the Warburg effect in precancerous lesions. Journal of Cancer 12 (05) 1563-1574 https://doi.org/10.7150/jca.54252
• 26 Nam M, Seo S. S, Jung S, Jang S. Y, Lee J, Kwon M, Khan I, Ryu D. H, Kim M. K, Hwang G. S. (2021). Comparable Plasma Lipid Changes in Patients with High-Grade Cervical Intraepithelial Neoplasia and Patients with Cervical Cancer. Journal of proteome research 20 (01) 740-750 https://doi.org/10.1021/acs.jproteome.0c00640
• 27 Cheng F, Wen Z, Feng X, Wang X, Chen Y. (2020). A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer. Life sciences 260: 118489-118489 https://doi.org/10.1016/j.lfs.2020.118489
• 28 Fontham ETH, Wolf AMD, Church TR. et al. Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society. CA Cancer J Clin. [Internet] 2020; [Access in: 03/08/2021]. Available in:
• 29 Ahmed-Salim Y, Galazis N, Bracewell-Milnes T, Phelps D. L, Jones B. P, Chan M, Munoz-Gonzales M. D, Matsuzono T, Smith J. R, Yazbek J, Krell J, Ghaem-Maghami S, Saso S. The application of metabolomics in ovarian cancer management: a systematic review. International journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyAdvance online publication. [Internet] 2020; [Access in: 02/23/2021] Available in:
• 30 Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cellular and molecular life sciences: CMLS, [Internet] 2016; [Access in: 02/23/2021] 73 (02) 377-392 Available in: https://doi.org/10.1007/s00018-015-2070-4
• 31 Turkoglu O, Zeb A, Graham S, Szyperski T, Szender J. B, Odunsi K, Bahado-Singh R. Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature. Metabolomics: Official journal of the Metabolomic Society. [Internet] 2016; [Access in: 02/27/2021] 12 (04) 60-60 Available in: https://doi.org/10.1007/s11306-016-0990-0
• 32 Kanehisa M. Toward pathway engineering: a new database of genetic and molecular pathways. Science & Technology Japan, [Internet] 1996; [Access in: 02/27/2021]. (59) 34-38 Available in: https://www.kanehisa.jp/docs/archive/stj.pdf
• 33 Liberti M. V, Locasale J. W. The Warburg Effect: How Does it Benefit Cancer Cells?. Trends in biochemical sciences. [Internet] 2016; [Access in: 02/27/2021] 41 (03) 211-218 Available in: https://doi.org/10.1016/j.tibs.2015.12.001
• 34 Hsu P. P, Sabatini D. M. Cancer cell metabolism: Warburg and beyond. Cell, [Internet] 2008; [Access in: 03/14/2021] 134 (05) 703-707 Available in: https://doi.org/10.1016/j.cell.2008.08.021
• 35 Vazquez A, Liu J, Zhou Y, Oltvai Z. N. Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited. BMC systems biology, [Internet] 2010; [Access in: 03/23/2021] 4: 58-58 Available in: https://doi.org/10.1016/j.tibs.2015.12.001
• 36 Pascale R. M, Calvisi D. F, Simile M. M, Feo C. F, Feo F. The Warburg Effect 97 Years after Its Discovery. Cancers. [Internet] 2020; [Access in: 02/27/2021] 12 (10) 2819-2819 Available in: https://doi.org/10.3390/cancers12102819
• 37 Wang H, Tso V. K, Slupsky C. M, Fedorak R. N. Metabolomics and detection of colorectal cancer in humans: a systematic review. Future oncology (London, England). [Internet] 2010; [Access in: 02/27/2021] 6 (09) 1395-1406 Available in: https://doi.org/10.2217/fon.10.107
• 38 Glunde K, Penet M. F, Jiang L, Jacobs M. A, Bhujwalla Z. M. Choline metabolism-based molecular diagnosis of cancer: an update. Expert review of molecular diagnostics. [Internet] 2015; [Access in: 02/27/2021] 15 (06) 735-747 Available in: https://doi.org/10.1586/14737159.2015.1039515
• 39 Ridgway N. D. The role of phosphatidylcholine and choline metabolites to cell proliferation and survival. Critical reviews in biochemistry and molecular biology. [Internet] 2013; [Access in: 02/23/2021] 48 (01) 20-38 Available in: https://doi.org/10.3109/10409238.2012.735643
• 40 Rižner T. L. Discovery of biomarkers for endometrial cancer: current status and prospects. Expert review of molecular diagnostics. [Internet] 2016; [Access in: 03/02/2021] 16 (12) 1315-1336 1258302 Available in: https://doi.org/10.1080/14737159.2016